No blood markers for predicting postoperative AE-ILD caused by lung resection have been reported; therefore, this study showed that HMGB1 can be a promising biomarker for predicting postoperative AE-ILD in patients with lung cancer and ILD, especially in those treated with lobectomy. This evidence concerns the gene HMGB1 and interstitial lung disease.